ERBB2 and breast carcinoma: In line with our results on hMena11a phosphorylation, Janssens K and coauthors [22] report that Evl-I is strongly phosphorylated in the HER2 overexpressing SKBr3 breast cancer cell line, whereas a lower level of P-Evl-I expression is shown in MCF7 and T47D cells.